Liver Cancer

Oncology Solutions

Liver cancer is the fifth most common cancer, accounting for 8.2 percent of all cancer deaths worldwide.1 The incidence is rising across all continents including in the United States. A study published in JAMA Oncology, December 2017 found the incidence of liver cancer increased by 75 percent worldwide between 1990 and 2015.2 Effective surveillance programs with imaging could offer early diagnosis and provide an opportunity for better treatment options.

The Patient Journey

  • LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

  • LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

  • Computed Tomography

    저선량에서 더 높은 생산성과 효율성을 제공하는 고품질의 환자 치료의 중요성이 점점 높아지고 있습니다.  따라서 GE는 이러한 의료진의 요구에 부응할 수 있는 CT 시스템 개발에 최선을 다하고 있습니다. 
    의료진은 GE Healthcare 의 CT 제품군 중에서 정확한 영상화 요구에...
  • LOGIQ™ E10 Ultrasound Series

    Next-generation, leadership ultrasound that adapts to your needs, today and into the future.

The latest in Oncology


1. IARC database of 2018.
2. JAMA Oncol. 2017;3(12):1683-1691. doi:10.1001/jamaoncol.2017.3055Published online October 5, 2017. Corrected on December 14, 2017.

JB04641XX